Показано 0 из 0
Дата |
---|
03.05.2024 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
0.96
|
1.00
|
1.14
|
0.91
|
1.1499
|
0.9646
|
|
|
170 385.49
|
451.00
|
1.08
|
1.13
|
1.02
|
1.01
|
1.16
|
1.12
|
|
|
256 010.77
|
644.00
|
0.979
|
1.04
|
0.96
|
0.96
|
1.04
|
1.04
|
|
|
62 043.36
|
236.00
|
0.8703
|
1.00
|
0.8505
|
0.8494
|
0.959
|
0.91715
|
|
|
31 311.23
|
179.00
|
0.8643
|
0.90
|
0.89
|
0.8412
|
0.8935
|
0.8741
|
|
|
18 450.30
|
90.00
|
0.842
|
0.89
|
0.8684
|
0.84
|
0.9299
|
0.8801
|
|
|
7 697.72
|
58.00
|
0.8201
|
0.90
|
0.8305
|
0.8274
|
0.90
|
0.84
|
|
|
50 502.09
|
168.00
|
0.8203
|
1.06
|
0.8578
|
0.85
|
0.8975
|
0.87
|
|
|
20 237.55
|
125.00
|
0.87
|
0.8787
|
0.920599
|
0.8601
|
0.920599
|
0.8787
|
|
|
33 041.57
|
165.00
|
0.886
|
1.03
|
0.8968
|
0.8344
|
0.94
|
0.886
|
|
|
65 697.79
|
221.00
|
Cingulate Inc. operates as a clinical stage biopharmaceutical company. The Company develops pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes.